Palliative chemotherapy: A clinical oxymoron [7]

Lancet

Volumn 362, Issue 9389, 2003, Pages 1082-

  Jefford, Michael ^a   Zalcberg, John ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVANCED CANCER; BREAST METASTASIS; CANCER CHEMOTHERAPY; CANCER SURVIVAL; HUMAN; LETTER; METASTASIS; PALLIATIVE THERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL TIME;

EID: 0141425675     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)14433-9     Document Type: Letter

References (5)

1. Anon. Collins essential English dictionary. Glasgow: Harper Collins, 2003.
2. Doyle D., Hanke G., MacDonald N. Oxford textbook of palliative medicine. 2nd edn :1999;Oxford University Press, New York.
3. Duric V., Stokker M. Patients' preferences for adjuvant chemotherapy in early breast cancer: a review of what makes it worthwile. Lancet Oncol. 2:2001;691-697.
4. Haines I.E., Zalcberg J., Buchanan J.D. Not-for-resuscitation orders in cancer patients - principles of decision-making. Med J Aust. 153:1990;225-229.
5. Colorectal Meta-analysis Collaboration. Palliative chemotherapy for advanced or metastatic colorectal cancer (Cochrane Review). In: The Cochrane Library, Issue 3, 2003. Oxford: Update Software.